Malakoplakia In Lung Transplant Recipients: Case Series.

Area of Science:

• Transplantation immunology
• Rare inflammatory disorders
• Infectious complications in immunocompromised patients

Background:

• Malakoplakia is a rare granulomatous inflammatory condition linked to impaired macrophage bactericidal activity.
• It predominantly affects immunocompromised individuals and is associated with chronic bacterial infections.
• Limited data exists on malakoplakia occurrence in lung transplant recipients.

Purpose of the Study:

• To describe the clinical characteristics, management, and outcomes of malakoplakia in lung transplant recipients.
• To analyze the presentation, microbiology, and treatment strategies for this rare complication.
• To identify risk factors and recurrence patterns in the context of solid organ transplantation.

Main Methods:

• Retrospective review of lung transplant recipients diagnosed with malakoplakia.
• Descriptive analysis of clinical presentation, microbiology, and management.
• Evaluation of patient outcomes and recurrence rates.

Main Results:

• Six episodes of malakoplakia occurred in five lung transplant recipients between 5 and 19 months post-transplant.
• Heterogeneous organ involvement included bladder, lung, colon, lymph nodes, soft tissues, and prostate.
• One patient had recurrent pulmonary malakoplakia 77 months post-transplant; chronic bacterial infection was noted in all cases.

Conclusions:

• Malakoplakia is an infrequent but significant complication following lung transplantation.
• Diverse clinical manifestations and a potential for recurrence necessitate vigilant management.
• Optimal care involves early tissue diagnosis, targeted antimicrobial therapy, and adjusted immunosuppression.